1-7 of 7
Alfonso D'Arco
Close
Sort by
Journal Articles

High Doses of Antimetabolites Followed By High-Dose Sequential Chemoimmunotherapy and Autologous Stem Cell Transplant in Patients with Systemic B-Cell Lymphoma and Secondary Central Nervous System Involvement: Final Results of a Multicenter Phase II Trial

Andrés J.M. Ferreri, Giovanni Donadoni, MD, Maria Giuseppina Cabras, MD, Caterina Patti, MD, Michael Mian, Renato Zambello, MD, Corrado Tarella, MD, Massimo Di Nicola, MD, Alfonso D'Arco, Gianluca Doa, Marta Bruno-Ventre, Marco Foppoli, MD, Alessandro Fanni, MD, Antonino Mulè, MD, Fabio Ciceri, MD, Federico Caligaris-Cappio, MD
Journal: Blood
Blood (2014) 124 (21): 1724.
https://doi.org/10.1182/blood.V124.21.1724.1724
Published: 2014
Journal Articles

Panobinostat As Salvage Treatment for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible to High Dose Therapy: A Phase II Study of the Fondazione Italiana Linfomi (FIL)

Francesco Zaja, Stefano Volpetti, Annalisa Chiappella, MD, Flavia Salvi, MD, Angelo M. Carella, Adalberto Ibatici, Pier Paolo Piccaluga, Stefano A. Pileri, Davide Rossi, MD PhD, Pier Luigi Zinzani, Caterina Patti, Umberto Vitolo, Alfonso D'Arco, Alessandra Tucci, Silvia Franceschetti, Andrea Evangelista, Valentina Lenti, Renato Fanin, Alessandro Levis
Journal: Blood
Blood (2014) 124 (21): 1755.
https://doi.org/10.1182/blood.V124.21.1755.1755
Published: 2014
Journal Articles

Safety and Efficacy of Bendamustine with or without Rituximab for the Treatment of Heavily Pretreated CLL and Lymphoma Patients. A Multicenter Retrospective Study.

Luigi Rigacci, Benedetta Puccini, Enrico Orciuolo, Alfonso D'Arco, Sergio Storti, Gianluca Gaidano, Roberto Freilone, Nicola Di Renzo, MD, Caterina Patti, MD, Alessandro Isidori, MD, PhD, Pier Luigi Zinzani, MD, Marco Gobbi, MD, Pellegrino Musto, MD, Anna Marina Liberati, MD, Andrea Carpaneto, Sergio Cortelazzo, Nicola Cascavilla, MD, Nadia Cecconi, Valeria Belsito Petrizzi, Giulio Giordano, MD, Silvia Franceschetti, Atto Billio, Alberto Bosi, MD
Journal: Blood
Blood (2009) 114 (22): 1662.
https://doi.org/10.1182/blood.V114.22.1662.1662
Published: 2009
Journal Articles

A Phase III Study of Enoxaparin Versus Low-Dose Warfarin Versus Aspirin as Thromboprophylaxis for Patients with Newly Diagnosed Multiple Myeloma Treated up-Front with Thalidomide-Containing Regimens

Michele Cavo, MD, Antonio Palumbo, M.D., Sara Bringhen, M.D., Antonietta Falcone, M.D., Pellegrino Musto, M.D., Fabio Ciceri, M.D., Mariella Grasso, M.D., Renato Zambello, M.D., Maria Concetta Petti, M.D., Fabrizio Ciambelli, M.D., Giovanni De Sabbata, M.D., Stefano Rocco, M.D., Luigi Gugliotta, M.D., Filippo Gherlinzoni, M.D., Alfonso D’Arco, M.D., Massimo Martelli, M.D., Tommasina Guglielmelli, M.D., Paola Tacchetti, M.D., Michele Baccarani, M.D., Mario Boccadoro
Journal: Blood
Blood (2008) 112 (11): 3017.
https://doi.org/10.1182/blood.V112.11.3017.3017
Published: 2008
Journal Articles

Fotemustine, Etoposide, Aracytin and Melphalan (FEAM), a Different Conditioning Regimen for Lymphoma Treatment with Autologous Hemopoietic Stem-Cell Transplantation

Maurizio Musso, Renato Scalone, Alessandra Crescimanno, Antonio Pinto, Gianpaolo Marcacci, Nicola Cascavilla, Potito Rosario Scalzulli, Nicola Di Renzo, Rosella Matera, Alfonso D’Arco, Francesco Lanza, Paolo Di Bartolomeo, Paolo Di Carlo, Tania Perrone, Carlo Bianchini
Journal: Blood
Blood (2008) 112 (11): 4456.
https://doi.org/10.1182/blood.V112.11.4456.4456
Published: 2008
Journal Articles

Superior Rate of Complete Response with up-Front Velcade-Thalidomide-Dexamethasone Versus Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma Is Not Affected by Adverse Prognostic Factors, Including High-Risk Cytogenetic Abnormalities.

Michele Cavo, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Giulia Marzocchi, B.S., Sandra Durante, B.S., Renato Zambello, M.D., Chiara Nozzoli, M.D., Lucia Pantani, M.D., Paola Tacchetti, M.D., Luciano Masini, M.D., Michela Ceccolini, M.D., Paola Agostini, M.D., Elena Zamagni, M.D., Valerio De Stefano, M.D., Patrizia Tosi, M.D., Daniele Derudas, M.D., Laura Dessanti, M.D., Stelvio Ballanti, M.D., Salvatore Palmieri, M.D., Andrea Nozza, M.D., Gioacchino Catania, M.D., Jacopo Peccatori, M.D., Alfonso D’Arco, M.D., Pellegrino Musto, M.D., Mariella Grasso, M.D., Maria Caterina Pallotti, M.D., Silvana Pasini, M.D., Pier Paolo Fattori, M.D., Anna Baraldi, M.D., Delia Cangini, M.D., Filippo Ballerini, M.D., Alessandro Petrucci, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2008) 112 (11): 1662.
https://doi.org/10.1182/blood.V112.11.1662.1662
Published: 2008
Journal Articles

Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone

Patrizia Tosi, Elena Zamagni, Delia Cangini, Paola Tacchetti, Francesco Di Raimondo, Lucio Catalano, Alfonso D'Arco, Sonia Ronconi, Claudia Cellini, Massimo Offidani, Giulia Perrone, Michela Ceccolini, Annamaria Brioli, Sante Tura, Michele Baccarani, Michele Cavo
Journal: Blood
Blood (2006) 108 (12): 3951–3952.
https://doi.org/10.1182/blood-2006-07-033571
Published: 2006